Pharmacotherapy o ka hoʻohui la i ka moe kolohe (2020)

Nā Hōʻailona Pelekikena (LE Marshall a me H Moulden, Hoʻoponopono Paukū)

Kau ʻia: 07 Mei 2020, Leo Malandain, ʻO Jean-Victor Blanc, Florian FerreriKahakau Kahuna

Nā Pūʻulu Manaʻo Kōkua o kēia manawa Volume 22, Helu ʻatikala: 30 (2020)

Hōʻuluʻulu Manaʻo

Hōʻike Pono

Ua hoʻomaikaʻi mākou i nā ʻikepili hou nei e pili ana i ka hana kolohe a me kāna hana. Ua nānā mākou i nā wehewehe like ʻole o kēia maʻi, pili e pili ana i nā hana pathophysiological. Ua kūkā mākou i ka lapaʻau lāʻau lapaʻau e pili ana i ka hoʻohui wahine.

Loaʻa hou

Hiki i ke ʻano hypersexual ke noʻonoʻo i kahi maʻi addictive. Hoʻohui ʻia ka mea pili kino e ka psychiatric koʻikoʻi a me nā comorbidities addictive a nona ke kuleana no ka pohō. Pono e hoʻolālā ʻia kahi hoʻolālā holoʻokoʻa a pono hoʻi.

hōʻuluʻulu manaʻo

ʻO nā mea hoʻohui me ka serotonin reuptake inhibitors e like me ka lālani lāʻau lapaʻau mua ka lāʻau no ka hoʻohui wahine. Hiki iā Naltrexone ke koho olakino hou aʻe. Pono e hoʻohana ʻia ka maʻi psychotherapy a me ka makemake cognitive-conductal therapy e hui pū me ka ʻoihana lapaʻau a me ka mālama ʻana i nā comorbidities.